Find a Study

STUDY SEARCH RESULTS
  Notify Me When Search is Updated

1 study found for your search request:  3543-017

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Condition: Thrombocythemia, Essential, Primary Myelofibrosis, Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06351631
Status: Recruiting
Has Enrolling Locations in US or Canada



Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site

Accessibility icon